Forsyth René, Sun Zhong-Hua, Reid Christopher, Moorin Rachael
Department of Medical Radiation Sciences, Curtin University, Perth, Australia.
School of Public Health, NHMRC Centre of Research Excellence in Cardiovascular Outcomes Improvement, Perth, Australia.
J Geriatr Cardiol. 2020 Jun;17(6):321-329. doi: 10.11909/j.issn.1671-5411.2020.06.001.
Key performance indices such as door-to-balloon times have long been recognized as quality metrics in reducing time to care for patients with acute coronary syndromes (ACS). In the situation where patients do not present to a facility capable of 24/7 percutaneous coronary interventions (PCI) delays in time to therapy can exceed the recommendation of 90 min or less. This study aimed to evaluate the impact of transfers on performance indices for patients diagnosed with ST-segment elevation myocardial infarction (STEMI).
Over a seven month collection period, all patients presenting with symptoms suggestive of ACS and admitted for PCI were studied. Patients were divided into dichotomous groups of direct presentations or transfers from a secondary non-PCI capable hospital with key times recorded, including symptom-onset, first hospital and PCI-capable hospital arrival and balloon inflation times to evaluate time of treatment for STEMI patients.
Of the 87 patients diagnosed with STEMI, transferred patients experienced statistically significant delays in symptom-onset to the PCI-capable hospital (PCI-H) arrival (215 95 min, < 0.001), symptom-onset to balloon inflation (225 160 min, = 0.009) and first hospital arrival to balloon inflation times (106 56 min, < 0.001). Only 28% ( = 9) of transferred patients underwent balloon inflation within 90 min from first hospital arrival, while 60% ( = 19) did within 120 min, although all received balloon inflation within 90 min from arrival at the PCI-H. After controlling for confounding factors of socio-economic status, presentation date/time and diagnostic category, transferred patients experienced an average 162% longer delays from symptom-onset to PCI-H door arrival, and 98% longer delays in symptom-onset to balloon inflation; compared to patients who present directly to the PCI-H. No statistically significant differences were noted between transferred and direct patients when measured from PCI-H door-to-balloon times.
This study shows that transferred patients experience a greater overall system delay, compared to patients who present directly for PCI, significantly increasing their time to treatment and therefore infarct times. Despite the majority of transfers experiencing pre-hospital activation, their treatment hospital arrival to balloon times are no less than direct presenters after controlling for confounding factors, further compounding the overall delay to therapy.
诸如门球时间等关键绩效指标长期以来一直被视为减少急性冠状动脉综合征(ACS)患者治疗时间的质量指标。在患者未前往具备全天候经皮冠状动脉介入治疗(PCI)能力的医疗机构的情况下,治疗延迟时间可能超过90分钟或更短时间的建议。本研究旨在评估转运对被诊断为ST段抬高型心肌梗死(STEMI)患者绩效指标的影响。
在七个月的收集期内,对所有出现ACS症状并接受PCI治疗的患者进行研究。患者被分为直接就诊组或从二级无PCI能力医院转运而来的两组,记录关键时间,包括症状发作、首次医院和具备PCI能力医院到达以及球囊扩张时间,以评估STEMI患者的治疗时间。
在87例被诊断为STEMI的患者中,转运患者在症状发作至具备PCI能力医院(PCI-H)到达(215±95分钟,P<0.001)、症状发作至球囊扩张(225±160分钟,P = 0.009)以及首次医院到达至球囊扩张时间(106±56分钟,P<0.001)方面存在统计学上的显著延迟。只有28%(n = 9)的转运患者在首次医院到达后90分钟内进行了球囊扩张,而60%(n = 19)在120分钟内进行了球囊扩张,尽管所有患者在到达PCI-H后90分钟内都进行了球囊扩张。在控制了社会经济地位、就诊日期/时间和诊断类别等混杂因素后,与直接前往PCI-H的患者相比,转运患者从症状发作到PCI-H门到达的平均延迟时间长162%,症状发作到球囊扩张的延迟时间长98%。从PCI-H门球时间测量时,转运患者和直接就诊患者之间未发现统计学上的显著差异。
本研究表明,与直接接受PCI治疗的患者相比,转运患者经历了更大的整体系统延迟,显著增加了他们的治疗时间,从而增加了梗死时间。尽管大多数转运患者在院前被激活,但在控制混杂因素后,他们的治疗医院到达至球囊时间并不少于直接就诊者,进一步加剧了整体治疗延迟。